ClinicalTrials.Veeva

Menu

The Effects of Intraoperative Dexmedetomidine Infusion on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy

Yonsei University logo

Yonsei University

Status and phase

Completed
Phase 4

Conditions

Gastric Cancer Patients Undergoing Laparoscopic Gastrectomy

Treatments

Drug: the control group
Drug: the dexmedetomidine group

Study type

Interventional

Funder types

Other

Identifiers

NCT02164448
4-2014-0249

Details and patient eligibility

About

The investigators hypothesized that sympatholytic effect of dexmedetomidine would attenuate the hemodynamic instability and decrease in the splanchnic blood flow caused by pneumoperitoneum during laparoscopic surgery. This study is to investigate the effect of intraoperative dexmedetomidine infusion on postoperative bowel movement in patients undergoing laparoscopic gastrectomy.

Enrollment

92 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient between 20 and 65 of age with ASA physical status Ⅰ-Ⅲ
  • gastric cancer patient undergoing laparoscopic gastrectomy

Exclusion criteria

  • ASA physical status Ⅳ
  • bradycardia (< 60 bpm), arrhythmia
  • uncompensated heart failure
  • hepatic failure (Child-Pugh score B 이상)
  • renal failure (eGFR MDRD < 60 ml/min/1.73m2)

Trial design

92 participants in 2 patient groups, including a placebo group

dexmedetomidine group
Experimental group
Treatment:
Drug: the dexmedetomidine group
control group
Placebo Comparator group
Treatment:
Drug: the control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems